Annual Statements Open main menu

Forza Innovations Inc - Quarter Report: 2023 March (Form 10-Q)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

_________________

FORM 10-Q

_________________

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2023

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

_________________

FORZA INNOVATIONS INC.

_________________

Wyoming 000-56131 30-0852686
(State or Other Jurisdiction (Commission (I.R.S. Employer
of Incorporation or Organization) File Number) Identification No.)

406 9th Avenue, Suite 210, San Diego, California 92101

(Address of Principal Executive Offices) (Zip Code)

 

(619) 324-7388
(Registrant’s telephone number, including area code)

___________________________________

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act: None.

Title of each class  Trading Symbol(s)  Name of each exchange on which registered
     
     
     
     

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒  No ☐ 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files.)

Yes ☒  No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐

Accelerated filer ☐

Non-accelerated filer Smaller reporting company
  Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

Yes ☐  No ☒

APPLICABLE ONLY TO CORPORATE ISSUERS

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date:  As of May 19, 2023, the issuer had 1,364,972,026 shares of its common stock issued and outstanding.

 1 

 

FORZA INNOVATIONS INC.

TABLE OF CONTENTS

PART I  
Item 1. Condensed Unaudited Financial Statements 4
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 16
Item 3. Quantitative and Qualitative Disclosures About Market Risk 20
Item 4. Controls and Procedures 20
PART II  
Item 1. Legal Proceedings 21
Item 1A. Risk Factors 21
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 21
Item 3. Defaults Upon Senior Securities 21
Item 4. Mining Safety Disclosures 21
Item 5. Other Information 21
Item 6. Exhibits 21
Signatures  22

 2 

 

 

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

FORZA INNOVATIONS INC.

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

Consolidated Balance Sheets as of March 31, 2023 (Unaudited) and June 30, 2022 (Audited) 4
Consolidated Statements of Operations for the three and nine months ended March 31, 2023 and 2022(Unaudited) 5
Consolidated Statements of Stockholders’ Equity (Deficit) for the three and nine months ended  March 31, 2023 and 2022 (Unaudited) 6
Consolidated Statements of Cash Flows for the nine months ended March 31, 2023 and 2022 (Unaudited) 8
Notes to the Consolidated Financial Statements (Unaudited) 9

 

 3 

 

 

 

FORZA INNOVATIONS INC.

CONSOLIDATED BALANCE SHEETS

 

           
   March 31, 2023  June 30, 2022
   (Unaudited)      
ASSETS          
Current assets:          
Cash  $12,638   $295,914 
Prepaid         5,130 
Loans receivable   46,250       
Total current assets   58,888    301,044 
Machinery and equipment, net   187,347    155,599 
Other assets   5,913    5,913 
Total other assets   193,260    161,512 
Total Assets  $252,148   $462,556 
           
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)          
Current liabilities:          
Accounts payable and accrued liabilities  $109,025   $49,972 
Accrued interest   200,842    129,564 
Convertible notes payable, net of discount of $199,787 and $424,889, respectively   1,502,005    905,111 
Derivative liability   1,063,934    662,982 
Loan payable   22,729    22,729 
Due to related party   19,306    19,406 
Total current liabilities   2,917,841    1,789,764 
Total liabilities   2,917,841    1,789,764 
           
Commitments and contingencies            
           
Stockholders' equity (deficit):          
Class B Preferred stock, $0.001 par value, 25,000,000 shares authorized, 10,000,000 issued and outstanding   10,000    10,000 
Common stock, $0.001 par value, 10,000,000,000 shares authorized; 1,229,887,991 and 220,009,575 shares issued and outstanding, respectively   1,229,888    220,009 
Common stock to be issued   26,231    26,231 
Additional paid-in capital   5,042,872    4,611,790 
Accumulated deficit   (8,974,684)   (6,195,238)
Total stockholders' deficit   (2,665,693)   (1,327,208)
Total Liabilities and Stockholders' Deficit  $252,148   $462,556 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 4 

 

 

FORZA INNOVATIONS INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

             
   For the Three Months Ended March 31,  For the Nine Months Ended March 31,
   2023  2022  2023  2022
Revenue  $39,954   $     $100,552   $   
Cost of revenue   356          26,556       
Gross margin   39,598          73,996       
                     
Operating Expenses:                    
General & administrative expenses   80,134    223,624    223,718    359,221 
Advertising and marketing   1,888          31,405       
Compensation expense   86,938    101,176    436,942    211,456 
Professional fees   42,544    81,730    201,684    112,741 
Stock based compensation   126,066          423,510    854,550 
Total operating expenses   337,570    406,530    1,317,259    1,537,968 
                     
Loss from operations   (297,972)   (406,530)   (1,243,263)   (1,537,968)
                     
Other income (expense):                    
Interest expense   (54,639)   (72,715)   (135,028)   (90,007)
Loss on issuance of convertible debt         (796,436)   (85,083)   (1,095,146)
Loss on conversion of debt   (32,719)         (209,000)      
Change in fair value of derivatives   (586,251)   385,084    (586,829)   516,136 
Debt discount amortization   (107,770)   (108,633)   (508,093)   (140,728)
Early payment penalty               (12,150)      
Total other expense   (781,379)   (592,700)   (1,536,183)   (809,745)
                     
Loss before income taxes   (1,079,351)   (999,230)   (2,779,446)   (2,347,713)
Provision for income taxes                        
Net Loss  $(1,079,351)  $(999,230)  $(2,779,446)  $(2,347,713)
Net loss per common share, basic & diluted  $(0.00)  $(0.00)  $(0.00)  $(0.00)
Weighted common shares outstanding, basic & diluted   908,032,890    295,432,901    583,684,383    288,361,958 

 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 5 

 

FORZA INNOVATIONS INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

FOR THE THREE AND NINE MONTHS ENDED MARCH 31, 2023

(Unaudited)

 

                         
   Common Shares  Common Stock  Preferred
Shares
  Preferred Stock  Paid in Capital  Common stock to be Issued  Accumulated Deficit  Total
Balance, June 30, 2022   220,009,575   $220,009   10,000,000   $10,000   $4,611,790   $26,231   $(6,195,238)  $(1,327,208)
Shares issued for conversion of debt   74,714,953   74,715   —            280,337                355,052 
Fair value of warrants granted   —        —            188,675                188,675 
Shares issues – related party   100,000,000   100,000   —            (100,000)                  
Net loss   —        —                        (838,003)   (838,003)
Balance, September 30, 2022   394,724,528   394,724   10,000,000    10,000    4,980,802    26,231    (7,033,241)   (1,621,484)
Shares issued for conversion of debt   385,434,463   385,435   —            99,663                485,098 
Fair value of warrants granted   —        —            108,769                108,769 
Net loss   —        —                        (862,092)   (862,092)
Balance, December 31, 2022   780,158,991   780,159   10,000,000    10,000    5,189,234    26,231    (7,895,333)   (1,889,709)
Shares issued for conversion of debt   449,729,900   449,729   —            (272,428)               177,301 
Fair value of warrants granted   —        —            126,066                126,066 
Net loss   —        —                        (1,079,351)   (1,079,351)
Balance, March 31, 2023   1,229,887,991   $1,229,888   10,000,000   $10,000   $5,042,872   $26,231   $(8,974,684)  $(2,665,693)

 

 

 

 

 6 

 

 

 

FORZA INNOVATIONS INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

FOR THE THREE AND NINE MONTHS ENDED MARCH 31, 2022

(Unaudited)

 

   Common Shares  Common Stock  Preferred
Shares
  Preferred Stock  Paid in Capital  Common stock to be Issued  Accumulated Deficit  Total Stockholders' Deficit
Balance, June 30, 2021   281,000,000   $281,000   10,000,000   $10,000   $2,921,000   $     $(3,494,730)  $(282,730)
Shares issued for conversion of debt   144,231   144   —            29,856    100,000          130,000 
Options exercised – related party   400,000   400   —            19,600                20,000 
Fair value of options granted   —        —            854,550                854,550 
Net loss   —        —                        (961,262)   (961,262)
Balance, September 30, 2021   281,554,231   281,544   10,000,000    10,000    3,825,006    100,000    (4,455,992)   (239,442)
Shares issued for conversion of debt   10,000,000   10,000   —            90,000    (100,000)            
Options exercised – related party   100,000   100   —            3,943                4,043 
Shares granted for financing costs   —         —                  3,431          3,431 
Net loss   —        —                        (387,221)   (387,221)
Balance, December 31, 2021   291,644,231   291,644   10,000,000    10,000    3,918,949    3,431    (4,843,213)   (619,189)
Shares issued for conversion of debt   4,105,730   4,104   —            100,371                104,475 
Shares granted for financing costs   2,700,000   2,700   —            161,550                164,250 
Fair value of warrants granted   —        —            109,561                109,561 
Net loss   —        —                        (999,230)   (999,230)
Balance, March 31, 2022   298,449,961   $298,448   10,000,000   $10,000   $4,290,431   $3,431   $(5,842,443)  $(1,240,133)

 

The accompanying notes are an integral part of these unaudited consolidated financial statements

 7 

 

 

FORZA INNOVATIONS INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

 

       
   For the Nine Months Ended March 31,
   2023  2022
Cash flows from operating activities:          
Net Loss  $(2,779,446)  $(2,347,713)
Adjustments to reconcile net loss to net cash used by operating activities:          
Depreciation and amortization   50,561    24,208 
Debt discount amortization   508,093    140,728 
Loss on issuance of convertible debt   85,083    1,095,146 
Change in fair value of derivatives   586,829    (516,136)
Loss on conversion of debt   209,000       
Common stock is sued for services         167,680 
Other stock-based compensation   423,510    854,550 
Changes in operating assets and liabilities:          
Prepaids   5,130       
Accounts payable and accrued liabilities   59,052    (5,913)
Accrued interest   131,291    3,739 
Accrued compensation         90,007 
Net cash used by operating activities   (720,897)   (493,704)
           
Cash flows from investing activities:          
Purchase of property and equipment   (82,309)   (55,335)
Loans receivable   (46,250)      
Net cash used by investing activities   (128,559)   (55,335)
           
Cash flows from financing activities:          
Advances from related party         27,088 
Repayment of related party loans   (100)   (28,106)
Proceeds from convertible debt   846,280    942,450 
Repayment of convertible debt   (280,000)      
Proceeds from the exercise of options         24,043 
Net cash provided by financing activities   566,180    965,475 
Net change in cash   (283,276)   416,436 
Cash, beginning of period   295,914    13,677 
Cash, end of period  $12,638   $430,113 
           
Supplemental disclosure of cash flow information:          
Cash paid for interest  $     $   
Cash paid for taxes  $     $   
Supplemental non-cash disclosure:          
Common stock issued for conversion of debt  $441,738   $234,476 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 8 

 

 

FORZA INNOVATIONS INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2023

 

NOTE 1 - NATURE OF OPERATIONS

Forza Innovations Inc. (the “Company”) was incorporated on December 9, 2014, under the laws of the State of Florida. The Company was a diversified multi-industry manufacturer of complex metal components and products. We serve all general industrial markets such as Aerospace, Automotive, Commercial, Food Processing, Industrial, Maritime, Medical, Railroad, Oil and Gas, Packaging, Telecom, Textiles, Robotics, Space Travel, Transportation and many more. We are a vertically integrated precision CNC manufacturing and fabrication company with core emphasis on product design, engineering and precision manufacturing of complex components and products.

On February 5, 2018, the Company formed Genesys Industries, LLC as a wholly owned subsidiary in the state of Missouri.

On January 21, 2021, Shefali Vibhakar, President of the Company closed a Share Purchase Agreement (the “Agreement”) that she entered into with Johnny Forzani to sell all of her 170,000,000 common shares and 10,000,000 preferred shares to Johnny Forzani for cash consideration of $177,000.

Further, as part of the Agreement, Ms. Vibhakar agrees to spin out all of the Company’s assets (except for certain machinery valued at $40,000 – which is subject to a separate purchase agreement) as well as all of the Company’s liabilities (except the Company’s note with Tangiers Capital, LLC). The value date of the assets and liabilities will be January 21, 2021.

On January 21, 2021, a change in control of the Company occurred pursuant to the Agreement. Mr. Forzani now has voting control over 93.9% of the Company’s issued and outstanding common stock.

On January 21, 2021, the Company received the resignation of Shefali Vibhakar as the Company’s President, Chief Executive Officer, Treasurer, Chief Financial Officer, Secretary and Director and appointed Johnny Forzani as its President, Chief Executive Officer, Treasurer, Chief Financial Officer and Secretary.

Effective January 21, 2021, the Company’s new address is 30 Forzani Way NW, Calgary, Alberta, Canada T3Z 1L5.

On February 17, 2021, the Company filed Articles of Continuance with the Secretary of State for the state of Wyoming. Accordingly, the Company transferred its state of formation from Florida to Wyoming and became a Wyoming entity.

On February 18, 2021, the Company filed a Certificate of Dissolution with the Secretary of State for the State of Florida, effectively dissolving the Company's existence in Florida.

As of June 30, 2021, Forza Innovations has moved out of the precision CNC manufacturing and fabrication business and has moved into the health-tech wearable performance business.  The Company has acquired the ownership and rights to certain late developmental stage products, including the J4 Sport, J4 X and J4 Fitbelt. These products are wearable back compression devices, used to relax, warmup, loosen, or relax stiff & sore muscles. The therapeutic application of heat causes a change in temperature of the soft tissues which decreases joint stiffness and relieves inflammation.  

On March 1, 2022, the Company entered into a Share Exchange Agreement (the “Agreement”) with Sustainable Origins Inc. (“Sustainable”), whereby the Company acquired 100% of the shares of Sustainable in exchange for 600,000 shares of the Company’s common stock and a cash payment of $17,000 and the payment of certain initial expenses, thereby making Sustainable a wholly-owned subsidiary of the Company. Sustainable is in the business of used cooking oil recycling and has recently entered into an asset purchase agreement with Oil Industries, Inc. of North Carolina to acquire certain assets related to the used cooking oil business. The Company valued the shares of common stock at $0.038, the closing stock price on the effective date of the agreement, for a valuation of $22,800. At the time of acquisition Sustainable had no operations. As such the Company fully impaired the $22,800. As of March 31, 2023, the shares have not yet been issued to Sustainable.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows at March 31, 2023 and for the related periods presented have been made. The results for the nine months ended March 31, 2023 are not necessarily indicative of the results of operations for the full year. These financial statements and related footnotes should be read in conjunction with the financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2022, filed with the Securities and Exchange Commission.

 9 

 

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Significant estimates include the estimated useful lives of property and equipment.  Actual results could differ from those estimates.

Concentrations of Credit Risk

We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash.

Cash Equivalents

The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents as of March 31, 2023 and June 30, 2022.

Principles of Consolidation

The accompanying unaudited consolidated financial statements for three and nine months ended March 31, 2023, include the accounts of the Company and its wholly owned subsidiary, Sustainable Origins. All material inter-company transactions have been eliminated in consolidation.

Reclassifications

Certain reclassifications have been made to the prior period financial information to conform to the presentation used in the financial statements for the period ended March 31, 2023.

Property, Plant and Equipment

Property and equipment are carried at the lower of cost or net realizable value. Major betterments that extend the useful lives of assets are also capitalized. Normal maintenance and repairs are charged to expense as incurred. When assets are sold or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized in operations.

Derivative Financial Instruments

The Company evaluates its convertible notes to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a weighted-average Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.

Fair Value of Financial Instruments

The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements.  To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels.  The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:

Level 1: Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.

Level 2: Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.

Level 3: Pricing inputs that are generally unobservable inputs and not corroborated by market data.

 10 

 

The carrying amount of the Company’s financial assets and liabilities, such as cash, prepaid expenses and accrued expenses approximate their fair value because of the short maturity of those instruments.  The Company’s notes payable amates the fair value of such instruments as the notes bear interest rates that are consistent with current market rates.

The following table classifies the Company’s asset measured at fair value on a recurring basis into the fair value hierarchy as of March 31, 2023 and June 30, 2022:

March 31, 2023

Schedule of fair value hierarchy         
Description  Level 1  Level 2  Level 3
Derivative   $     $     $1,063,934 
Total   $     $     $1,063,934 

June 30, 2022

Description  Level 1  Level 2  Level 3
Derivative   $     $     $662,982 
Total   $     $     $662,982 

Basic and Diluted Loss Per Share

Under ASC 260 “Earnings Per Share,” the Company presents basic and diluted earnings (loss) per-share (“EPS”) amounts on the face of the statements of operations. Basic EPS computed by dividing income (loss) available to common stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Shares issued during the period and shares reacquired during the period are weighted for the portion of the period that they were outstanding. The computation of diluted EPS is similar to the computation of basic EPS except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued. Potentially diluted amounts from preferred stock are not presented when the effect of the computations are anti-dilutive due to the losses incurred. Accordingly, there is no difference in the amounts presented for basic and diluted loss per share.

Recent Accounting Pronouncements

The Company has implemented all new applicable accounting pronouncements that are in effect.  These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

NOTE 3 - GOING CONCERN

The accompanying unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.  As of March 31, 2023, the Company has limited revenue and an accumulated deficit of $8,974,684 ($3,069,884 of which is from the FY 2021 loss on the asset acquisition and disposition of assets).

While the Company is successfully executing its growth strategy, its cash position may not still be sufficient to support the Company’s daily operations without additional financing. While the Company believes in the viability of its strategy to produce sales volume and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate sufficient revenues. The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Management believes that the actions presently being taken to further implement its business plan and generate revenues provide the opportunity for the Company to continue as a going concern.

NOTE 4 – MACHINERY AND EQUIPMENT

Long lived assets, including property and equipment and certain intangible assets to be held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Impairment losses are recognized if expected future cash flows of the related assets are less than their carrying values. Measurement of an impairment loss is based on the fair value of the asset. Long-lived assets and certain identifiable intangibles to be disposed of are reported at the lower of carrying amount or fair value less cost to sell.

 11 

 

Property and Equipment and intangible assets are first recorded at cost. Depreciation and/or amortization is computed using the straight-line method over the estimated useful lives of the various classes of assets between three and five years. Leasehold improvements are being depreciated over ten years, and the building over twenty years.

Maintenance and repair expenses, as incurred, are charged to expense. Betterments and renewals are capitalized in plant and equipment accounts. Cost and accumulated depreciation applicable to items replaced or retired are eliminated from the related accounts with any gain or loss on the disposition included as income.

Property and equipment stated at cost, less accumulated depreciation for continuing operations consisted of the following:

Property, plant & equipment          
   March 31, 2023  June 30, 2022
Machinery and Equipment  $222,793   $150,483 
Office Equipment   3,097    3,097 
Vehicles   51,720    41,720 
Less: accumulated depreciation   (90,263)   (39,701)
Property and equipment, net  $187,347   $155,599 

Depreciation expense

Depreciation expense for the nine months ended March 31, 2023 and 2022 was $50,561 and $24,208, respectively.

NOTE 5 – CONVERTIBLE NOTES PAYABLE

During the nine months ended March 31, 2023, the Company issued, paid and or converted the following new convertible promissory notes. 

Schedule of convertible promissory notes                            
Note Holder Date Maturity Date Interest Rate

Balance June 30, 2022

  Additions   Conversions  

Balance March 31, 2023

Fast Capital LLC (1) 10/26/2021 10/26/2022 10% $ 30,000   $   $ (30,000)   $
ONE44 Capital LLC (3) 1/13/2022 1/13/2023 10% $ 160,000   $   $ (34,300)   $ 125,700
Mast Hill Fund, L.P. (4) 1/20/2022 1/20/2023 12% $ 350,000   $   $ (297,688)   $ 52,312
Sixth Street Lending LLC (5) 2/1/2022 2/1/2023 10% $ 80,000   $   $ (80,000)   $
ONE44 Capital LLC (3) 3/22/2022 3/22/2023 10% $ 120,000   $   $   $ 120,000
Sixth Street Lending LLC (5) 4/13/2022 4/13/2023 10% $ 55,000   $   $ (55,000)   $
1800 Diagonal Lending LLC (5) 5/23/2022 5/23/2023 10% $ 55,000   $   $ (55,000)   $
Coventry Enterprises, LLC (2) 6/3/2022 6/3/2023 10% $ 480,000   $   $   $ 480,000
1800 Diagonal Lending LLC (5) 7/26/2022 7/26/2023 10% $   $ 59,250   $ (10,550)   $ 48,700
Mast Hill Fund, L.P. (6) 9/19/2022 9/19/2023 12% $   $ 290,000   $   $ 290,000
1800 Diagonal Lending LLC (5) 11/11/2022 11/11/2023 10% $   $ 44,250   $   $ 44,250
Mast Hill Fund, L.P. (7) 12/16/2022 12/16/2022 12% $   $ 233,000   $ (100,000)   $ 133,000
Mast Hill Fund, L.P. (8) 1/13/2023 12/16/2022 12% $   $ 347,060   $   $ 347,060
      Total $ 1,330,000   $ 973,560   $ (662,538)   $ 1,641,022
    Less debt discount $ (424,889)             $ (139,017)
  Convertible notes payable, net $ 905,111             $ 1,502,005

Conversion Terms

(1)61% of the lowest trading price for 15 days, including conversion date.
(2)Convertible only upon an event of default. 90% of the lowest trading price for 10 days prior to conversion date.
(3)60% of the lowest trading price for 20 days, including conversion date.
(4)Convertible only upon an event of default. Conversion would then be $0.10.
(5)61% of the lowest trading price for 15 days prior to conversion date.
(6)Convertible at $0.0015.
(7)Convertible at $0.0007.
   
(8) Convertible at $0.0003

Total accrued interest on the above convertible notes as of March 31, 2023, is $180,189.

 12 

 

A summary of the activity of the derivative liability for the notes above is as follows:  

Schedule of derivative liability     
Increase to derivative due to new issuances   1,648,566 
Decrease to derivative due to conversion/payments   (18,162)
Derivative gain due to mark to market adjustment   (967,422)
Balance at June 30, 2022   662,982 
Increase to derivative due to new issuances   180,083 
Decrease to derivative due to conversions   (365,960)
Derivative gain due to mark to market adjustment   586,829 
Balance at March 31, 2023  $1,063,934 

A summary of quantitative information about significant unobservable inputs (Level 3 inputs) used in measuring the Company’s derivative liability that are categorized within Level 3 of the fair value hierarchy as of March 31, 2023 is as follows:

Schedule of fair value hierarchy        
Inputs March 31, 2023 Initial
Valuation
Stock price $0.0002   $0.0014 0.0086 
Conversion price  $0.0001   $0.0006 - 0.0049 
Volatility (annual)  169.6% – 275.2%   210.52% - 237.49% 
Risk-free rate  4.85% - 4.94%   2.51% - 4.59 % 
Dividend rate          
Years to maturity  .25 .61   1 

NOTE 6 - NOTE PAYABLE

On November 5, 2017, to fund its working capital requirements the Company obtained a Special Line of Credit (“LOC”) also recognized as a Blanket Secured Promissory Note for the total draw down amount of up to $500,000, from Twiga Capital Partners, LLC (“TCP”), an entity controlled by the Company’s former sole officer and largest stockholder, Shefali Vibhakar. This Note is secured by all of the assets of the Company in accordance with the Security Agreement by and between the Company and the Holder dated as of November 5, 2017. The LOC bears interest at 5% per annum and is due on demand. On January 21, 2021, TCP assigned all of its rights, title and interest in the debt to Front Row Seating Inc. On September 28, 2021, $100,000 of the note was converted into 10,000,000 shares of common stock. As of March 31, 2023 and June 30, 2022, the Company owed $22,729 and $22,729 of principal and $20,654 and $19,796 of accrued interest, respectively.

NOTE 7 – COMMON STOCK

During the first quarter, Fast Capital LLC converted $30,000 and $4,550 of principal and interest, respectively, into 11,328,868 shares of common stock.

During the first quarter, One44 Capital LLC converted $15,000 and $744 of principal and interest, respectively, into 5,247,947 shares of common stock.

During the first quarter, 1800 Diagonal Lending converted $80,000 and $4,626 of principal and interest, respectively, into 34,739,138 shares of common stock.

During the first quarter, Mast Hill Fund, L.P converted $2,040 and $42,200 of principal and interest, respectively, into 23,400,000 shares of common stock. The Company recognized a loss on conversion of debt of $20,840.

During the second quarter, 1800 Diagonal Lending converted $110,000 and $5,500 of principal and interest, respectively, into 186,262,331 shares of common stock.

During the second quarter, Mast Hill Fund, L.P converted $121,607 of principal, into 210,500,000 shares of common stock. The Company recognized a loss on conversion of debt of $113,263.

During the third quarter, 1800 Diagonal Lending converted $10,550 of principal, into 87,916,334 shares of common stock.

During the third quarter, Mast Hill Fund, L.P converted $24,041 and $3,937 of principal and interest, respectively, into 182,700,000 shares of common stock. The Company recognized a loss on conversion of debt of $32,719

During the third quarter, One44 Capital LLC converted $19,300 and $2,193 of principal and interest, respectively, into 179,112,333 shares of common stock.

 13 

 

NOTE 8 – PREFERRED STOCK

On September 7, 2022, the Company filed with the Secretary of State of the State of Wyoming, an Articles of Amendment (the “Amendment”) designating the terms, preferences and rights of the 25,000,000 shares of the Company's previously authorized Class B Preferred Stock. Each share of Class B Preferred Stock entitles the holder thereof to ten thousand votes per share on all matters to be voted on by the holders of the Company’s common stock and is convertible into shares of the Company's common stock at the same rate. With respect to rights on liquidation, dissolution or winding up, shares of Class B Preferred Stock rank on parity with the Company's common stock.

NOTE 9 - RELATED PARTY TRANSACTIONS

Mr. Forzani has advanced the Company funds for general operating expenses, the advances are non-interest bearing and due on demand. As of March 31, 2023, and June 30, 2022, the Company owes Mr. Forzani $19,306 and $19,406, respectively.

On July 25, 2022, the Company reissued the 100,000,000 shares of common stock that were previously cancelled by its Mr. Forzani. The cancellation was reported on a Form 8-K filed June 15, 2022 (the “Previous 8-K”). Mr. Forzani temporarily cancelled his shares in order for the Company to complete the financing reported on the Previous 8-K.

NOTE 10– STOCK OPTIONS

On August 3, 2021, the Company granted 1,000,000 options to Johnny Forzani, CEO, 250,000 options to Geoff Stanbury, director, and 250,000 options to Tom Forzani, Director. The options were issued pursuant the Company’s 2021 Equity Award Plan. The options are exercisable at $0.05, are immediately vested and expire in two years.

A summary of the status of the Company’s outstanding stock options and changes during the period is presented below: 

Schedule of stock options outstanding               
Stock Options  Options  Weighted Average
Exercise
Price
  Aggregate
Intrinsic
Value
Options outstanding at June 30, 2021        $      —   
Granted   1,500,000   $0.05    —   
Exercised   (500,000)  $      —   
Expired        $      —   
Options outstanding at June 30, 2022   1,000,000   $0.05    —   
Granted        $      —   
Exercised        $      —   
Expired        $      —   
Options outstanding at March 31, 2023   1,000,000   $0.05    —   
Options exercisable at March 31, 2023   1,000,000   $0.05   $—   

 

Schedule of range of exercise prices         
Range of Exercise Prices  Number Outstanding
3/31/2023
  Weighted Average
Remaining Contractual
Life
  Weighted Average
Exercise Price
$0.05    1,000,000    .66 years   $0.05 

NOTE 11 – WARRANTS

On September 23, 2022, the Company, closed a Securities Purchase Agreement (the “Purchase Agreement”) with Mast Hill Fund, L.P., a Delaware limited partnership (“Mast Hill”), dated as of September 19, 2022, pursuant to which the Company issued Mast Hill a convertible promissory note in the principal amount of $290,000 (the “Note”), a five-year warrant to purchase up to 100,000,000 shares of common stock at a price of $0.003 per share (the “First Warrant”) and a warrant to purchase up to 100,000,000 shares of common stock at a price of $0.003 per share (the “Second Warrant”), which warrants are only exercisable upon an “Event of Default” as defined in the Note.

Using the fair value calculation, the relative fair value between the debt issued and the warrants was calculated to determine the warrants recorded equity amount of $188,675, accounted for in additional paid in capital.

On December 16, 2022, the Company, closed a Securities Purchase Agreement (the “Purchase Agreement”) with Mast Hill, pursuant to which the Company issued Mast Hill a convertible promissory note in the principal amount of $233,000 (the “Note”), a five-year warrant to purchase up to 155,000,000 shares of common stock at a price of $0.0015 per share (the “First Warrant”) and a warrant to purchase up to 100,000,000 shares of common stock at a price of $0.003 per share (the “Second Warrant”), which warrants are only exercisable upon an “Event of Default” as defined in the Note.

 14 

 

Using the fair value calculation, the relative fair value between the debt issued and the warrants was calculated to determine the warrants recorded equity amount of $108,769, accounted for in additional paid in capital.

A summary of the status of the Company’s outstanding stock options and changes during the period is presented below:

Schedule of warrant outstanding               
 Warrants  Warrants  Weighted Average
Exercise
Price
  Aggregate
Intrinsic
Value
Warrants outstanding at June 30, 2021        $      —   
Granted   1,950,000   $0.44    —   
Exercised        $      —   
Expired        $      —   
Warrants outstanding at June 30, 2022   1,950,000   $0.44    —   
Granted   455,000,000   $0.004    —   
Exercised       $      —   
Expired       $      —   
Warrants outstanding at March 31, 2023   456,950,000    $0. 004    —   
Warrants exercisable at March 31, 2023   456,950,000    $0. 004   $   

 

Schedule of range of exercise prices         
Range of Exercise Prices  Number Outstanding
3/31/2023
  Weighted Average
Remaining Contractual
Life
  Weighted Average
Exercise Price
 $0.0015 - 0.44    201,950,000    4.72 years   $0.004 

NOTE 12 - SUBSEQUENT EVENTS

In accordance with SFAS 165 (ASC 855-10) management has performed an evaluation of subsequent events through the date that the financial statements were available to be issued and has determined that it has no material subsequent events to disclose in these consolidated financial statements.

 

 15 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis should be read in conjunction with our unaudited financial statements, included herewith. This discussion should not be construed to imply that the results discussed herein will necessarily continue into the future, or that any conclusion reached herein will necessarily be indicative of actual operating results in the future. Such discussion represents only the best present assessment of our management.

Forward Looking Statements

Certain matters discussed herein are forward-looking statements. Such forward-looking statements contained in this Form 10-Q involve risks and uncertainties, including statements as to:

our future operating results;
our business prospects;
our contractual arrangements and relationships with third parties;
the dependence of our future success on the general economy;
our possible future financings; and
the adequacy of our cash resources and working capital.

These forward-looking statements can generally be identified as such because the context of the statement will include words such as we “believe,” “anticipate,” “expect,” “estimate” or words of similar meaning. Similarly, statements that describe our future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties which are described in close proximity to such statements and which could cause actual results to differ materially from those anticipated. Shareholders, potential investors and other readers are urged to consider these factors in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements included herein are only made as of the date of this Form 10-Q, and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

Cautionary Statement:

Statements included in this Management’s Discussion and Analysis of Financial Condition and Results of Operations, in future filings by the Company with the Securities and Exchange Commission, in the Company’s press releases and in oral statements made with the approval of an authorized executive officer that are not historical or current facts are “forward-looking statements.” These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and are subject to certain risks and uncertainties that could cause actual results to differ materially from historical earnings and those presently anticipated or projected. These risks and uncertainties are described in the Company’s Annual Report on Form 10-K for the year ended June 30, 2022, as well as other filings the Company makes with the Securities and Exchange Commission. The Company wishes to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made and are not predictions of actual future results. The Company disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

Plan of Operations

The Company has acquired the ownership and rights to certain late developmental stage products, including the J4 Sport, J4 X and J4 Fitbelt.  These products are wearable back compression devices, used to relax, warmup, loosen, or relax stiff & sore muscles.  The therapeutic application of heat causes a change in temperature of the soft tissues which decreases joint stiffness and relieves inflammation.  

We have recently successfully completed our first acquisition of “Sustainable Origins” which is an eco-friendly ESG company, that converts used cooking oil to reusable biodiesel. This acquisition is part of our ongoing strategic plan for future revenue and expansion. While our primary focus will always be revolving around the innovation of wearable technology, these projects will take time to market. We want to align ourselves with like-minded Entrepreneurs that will mesh well with our team and collective interest. Having the ability to acquire companies current operations to generate steady revenue streams, will also help aid in financing the production of “WarmUp” and other products we will develop.

 16 

 

Results of Operation for the Three Months Ended March 31, 2023 Compared to the Three Months March 31, 2022

Revenues and Cost of Revenue

We earned revenues of $39,954 during the three months ended March 31, 2023, compared to $nil for the same period in 2022. Our cost of revenue was $356 during the three months ended March 31, 2023, compared to $nil for the same period in 2022.

Operating Expenses from Continuing Operations

Operating expenses from continuing operations for the three months ended March 31, 2023 and 2022, were $337,570 and $406,530, respectively. We had general and administrative expenses (“G&A”) of $80,134 and $223,624, respectively.

Compensation Expense

Compensation expense for the three months ended March 31, 2023 and 2022, was $86,938 and $101,176, respectively. We are incurring compensation expense for both officers and newly hired employees.

Professional Fees

Professional fees for the three months ended March 31, 2023 and 2022, was $42,544 and $81,730, respectively. We incur professional fees for legal, audit, accounting and other consulting expense.

Net Loss from Continuing Operations

Our net loss from continuing operations for the three months ended March 31, 2023 was $1,079,351compared to $999,230 for the prior period.

Results of Operation for the Nine Months Ended March 31, 2023 Compared to the Nine Months Ended March 31, 2022

Revenues and Cost of Revenue

We earned revenues of $100,552 during the nine months ended March 31, 2023, compared to $nil for the same period in 2022. Our cost of revenue was $26,556 during the six months ended March 31, 2023, compared to $nil for the same period in 2022.

Operating Expenses from Continuing Operations

Operating expenses from continuing operations for the nine months ended March 31, 2023 and 2022, were $1,317,259 and $1,537,968, respectively. We had general and administrative expenses (“G&A”) of $223,718 and $359,221, respectively. G&A expenses for the nine months ended March 31, 2023.

Compensation Expense

Compensation expense for the nine months ended March 31, 2023 and 2022, was $436,942 and $211,456, respectively. We are incurring compensation expense for our officers and newly hired employees.

Professional Fees

Professional fees for the nine months ended March 31, 2023 and 2022, were $201,684 and $112,741, respectively. We incur professional fees for legal, audit, accounting and other consulting expense.

In the current period we also incurred an $423,510 non-cash expense for the issuance of stock options to our officers and directors compared to 854,550 for the prior period.

 17 

 

Net Loss from Continuing Operations

Our net loss from continuing operations for the nine months ended March 31, 2023 was $2,779,446 compared to $2,347,713 for the prior period. Our net loss in the current period largely consists of non-cash stock compensation expense and losses related the issuance of convertible debt and the related valuation of derivatives as discussed above.

Liquidity and Capital Resources

As reflected in the accompanying unaudited condensed consolidated financial statements, the Company has an accumulated deficit of $5,842,443 at March 31, 2023, and a net loss from continuing operations of $2,347,713 for the nine months ended March 31, 2023.

For the nine months ended March 31, 2023, we used $720,897 of cash in operating activities, compared to using $493,704 for the nine months ended March 31, 2022. In the current period we used more cash to pay for professional fees and compensation expense as well has increased expenditures on marketing activities.

For the nine months ended March 31, 2023, we used $128,559 of cash in investing activities, compared to using $55,335 for the nine months ended March 31, 2022.

Net cash received from financing activities for the nine months ended March 31, 2023, was $566,180 compared to $965,475 provided by financing activities in the prior period. In the current period we received $846,280 from the issuance of convertible debt.

On January 2, 2020, the Company executed a 10% convertible promissory note in which it agreed to borrow up to $300,000. The note is convertible at a price per share equal to the lower of (a) the Fixed Conversion Price (which is fixed at a price equal to $0.30); or (b) 80% of the lowest trading price of the Company’s common stock during the 5 consecutive trading days prior to the date on which lender elects to convert all or part of the Note. As of March 31, 2023 and June 30, 2022, there is $15,524 and $150,000 and $56,677 and $40,250 of principal and interest, due on this loan, respectively.

On November 5, 2017, to fund its working capital requirements the Company obtained a Special Line of Credit (“LOC”) also recognized as a Blanket Secured Promissory Note for the total draw down amount of up to $500,000, from Twiga Capital Partners, LLC (“TCP”), an entity controlled by the Company’s former sole officer and largest stockholder, Shefali Vibhakar. This Note is secured by all of the assets of the Company in accordance with the Security Agreement by and between the Company and the Holder dated as of November 5, 2017. The LOC bears interest at 5% per annum and is due on demand. On January 21, 2022, TCP assigned all of its rights, title and interest in the debt to Front Row Seating Inc. On September 28, 2022, $100,000 of the note was converted into 10,000,000 shares of common stock. As of March 31, 2023 and June 30, 2022, the Company owed $22,729 and $122,729 of principal and $19,512 and $17,399 of accrued interest, respectively.

 18 

 

During the nine months ended March 31, 2023, the Company issued, paid and or converted the following new convertible promissory notes.

Note Holder  Date  Maturity Date  Interest Rate  Balance
June 30, 2022
  Additions  Conversions  Balance
March 31, 2023
Fast Capital LLC (1)  10/26/2021  10/26/2022   10%  $30,000   $—     $(30,000)  $—   
ONE44 Capital LLC (3)  1/13/2022  1/13/2023   10%  $160,000   $—     $(34,300)  $125,700 
Mast Hill Fund, L.P. (4)  1/20/2022  1/20/2023   12%  $350,000   $—     $(297,688)  $52,312 
Sixth Street Lending LLC (5)  2/1/2022  2/1/2023   10%  $80,000   $—     $(80,000)  $—   
ONE44 Capital LLC (3)  3/22/2022  3/22/2023   10%  $120,000   $—     $—     $120,000 
Sixth Street Lending LLC (5)  4/13/2022  4/13/2023   10%  $55,000   $—     $(55,000)  $—   
1800 Diagonal Lending LLC (5)  5/23/2022  5/23/2023   10%  $55,000   $—     $(55,000)  $—   
Coventry Enterprises, LLC (2)  6/3/2022  6/3/2023   10%  $480,000   $—     $—     $480,000 
1800 Diagonal Lending LLC (5)  7/26/2022  7/26/2023   10%  $—     $59,250   $(10,550)  $48,700 
Mast Hill Fund, L.P. (6)  9/19/2022  9/19/2023   12%  $—     $290,000   $—     $290,000 
1800 Diagonal Lending LLC (5)  11/11/2022  11/11/2023   10%  $—     $44,250   $—     $44,250 
Mast Hill Fund, L.P. (7)  12/16/2022  12/16/2022   12%  $—     $233,000   $(100,000)  $133,000 
Mast Hill Fund, L.P. (8)  1/13/2023  12/16/2022   12%  $—     $347,060   $—     $347,060 
          Total   $1,330,000   $973,560   $(662,538)  $1,641,022 
   Less debt discount       $(424,889)            $(139,017)
  Convertible notes payable, net       $905,111             $1,502,005 

Conversion Terms

(1)61% of the lowest trading price for 15 days, including conversion date.
(2)Convertible only upon an event of default. 90% of the lowest trading price for 10 days prior to conversion date.
(3)60% of the lowest trading price for 20 days, including conversion date.
(4)Convertible only upon an event of default. Conversion would then be $0.10.
(5)61% of the lowest trading price for 15 days prior to conversion date.
(6)Convertible at $0.0015
(7)Convertible at $0.0007
(8)Convertible at $0.0003

Total accrued interest on the above convertible notes as of March 31, 2023, is $180,189.

Critical Accounting Estimates and Policies

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Note 1 to the Financial Statements describes the significant accounting policies and methods used in the preparation of the Financial Statements. Estimates are used for, but not limited to, contingencies and taxes.  Actual results could differ materially from those estimates. The following critical accounting policies are impacted significantly by judgments, assumptions, and estimates used in the preparation of the Financial Statements.

We are subject to various loss contingencies arising in the ordinary course of business.  We consider the likelihood of loss or impairment of an asset or the incurrence of a liability, as well as our ability to reasonably estimate the amount of loss in determining loss contingencies.  An estimated loss contingency is accrued when management concludes that it is probable that an asset has been impaired or a liability has been incurred and the amount of the loss can be reasonably estimated.  We regularly evaluate current information available to us to determine whether such accruals should be adjusted.

We recognize deferred tax assets (future tax benefits) and liabilities for the expected future tax consequences of temporary differences between the book carrying amounts and the tax basis of assets and liabilities.  The deferred tax assets and liabilities represent the expected future tax return consequences of those differences, which are expected to be either deductible or taxable when the assets and liabilities are recovered or settled.  Future tax benefits have been fully offset by a 100% valuation allowance as management is unable to determine that it is more likely than not that this deferred tax asset will be realized.

 19 

 

Off-Balance Sheet Arrangements 

We have not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources and would be considered material to investors.

Recent Accounting Pronouncements

The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on our financial position or results of operations.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable to smaller reporting companies.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are designed to be effective in providing reasonable assurance that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission (the “SEC”), and that such information is accumulated and communicated to our management to allow timely decisions regarding required disclosure. Our Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation, they concluded that our disclosure controls and procedures were effective for the quarterly period ended March 31, 2023.

In designing and evaluating disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute assurance of achieving the desired objectives. Also, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs.

Changes in Internal Controls

Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that no change occurred in the Company's internal controls over financial reporting during the quarter ended March 31, 2023, that has materially affected, or is reasonably likely to materially affect, the Company's internal controls over financial reporting.

 20 

 

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

There are not presently any material pending legal proceedings to which the Company is a party or as to which any of our property is subject, and no such proceedings are known to the Company to be threatened or contemplated against it.

ITEM 1A. RISK FACTORS

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and, as such, are not required to provide the information under this Item.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINING SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION.

None.

ITEM 6. EXHIBITS

No. Description
31.1 Certification of Chief Executive Officer and Chief Financial Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a).
32.1 Certifications pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.
101. INS XBRL Instance Document
101. SCH XBRL Taxonomy Extension Schema Document
101. CAL XBRL Taxonomy Calculation Linkbase Document
101. DEF XBRL Taxonomy Extension Definition Linkbase Document
101. LAB XBRL Taxonomy Label Linkbase Document
101. PRE XBRL Taxonomy Presentation Linkbase Document

 21 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Forza Innovations Inc.

   
   
   
Date:  May 22, 2023 /s/ Johnny Forzani
  Johnny Forzani
 

President, Chief Financial Officer, Treasurer, Chief Financial Officer, Secretary (Principal Executive, Financial and Accounting Officer)

 22